Related references
Note: Only part of the references are listed.Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA
Shripad Sinari et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)
Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII
Patricia Recio-Lopez et al.
BIOFACTORS (2023)
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia
Thomas A. Prohaska et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2023)
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial
Joseph L. Witztum et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2023)
Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice
Denis Sviridov et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)
Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease
Jeremy D. Furtado et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
Lean adolescents with insulin resistance display higher angiopoietin like protein 3, ApoC-III and chylomicron remnant dyslipidemia
Karla Paola Gutierrez Castro et al.
CLINICA CHIMICA ACTA (2022)
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2022)
Inflammatory Links Between Hypertriglyceridemia and Atherogenesis
Xueying Peng et al.
CURRENT ATHEROSCLEROSIS REPORTS (2022)
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Jan Boren et al.
NATURE REVIEWS CARDIOLOGY (2022)
Complex association of apolipoprotein E-containing HDL with coronary artery disease burden in cardiovascular disease
Alexander Sorokin et al.
JCI INSIGHT (2022)
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
Aruna Das Pradhan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials
Ilenia Calcaterra et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)
Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia
Ewa Karwatowska-Prokopczuk et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study
Elif A. Oral et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations
Marja-Riitta Taskinen et al.
JCI INSIGHT (2022)
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis
Angela Pirillo et al.
CARDIOVASCULAR RESEARCH (2021)
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL)
Azusa Yamazaki et al.
BIOLOGICAL CHEMISTRY (2021)
Lipoprotein Lipase and Its Regulators: An Unfolding Story
Shuangcheng Alivia Wu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study
Rain Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Jennifer Behbodikhah et al.
METABOLITES (2021)
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Ioanna Gouni-Berthold et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
Yunpeng Guan et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg et al.
EUROPEAN HEART JOURNAL (2021)
Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia
Zahid Ahmad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups
Shiwali Goyal et al.
LIPIDS IN HEALTH AND DISEASE (2021)
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg et al.
EUROPEAN HEART JOURNAL (2021)
HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia
Tianhua Zhang et al.
CLINICAL BIOCHEMISTRY (2020)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia
A. Baass et al.
JOURNAL OF INTERNAL MEDICINE (2020)
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides
Anna Wolska et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function
Monica Zilmer et al.
BRAIN (2020)
Causes and Consequences of Hypertriglyceridemia
Chris J. Packard et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Familial Partial Lipodystrophy (FPLD): Recent Insights
Christos Bagias et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Regulation of lipoprotein lipase-mediated lipolysis of triglycerides
Debapriya Basu et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Boren et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia
Manja Koch et al.
JAMA NETWORK OPEN (2020)
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity
Reyna Rodriguez-Mortera et al.
CLINICA CHIMICA ACTA (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
Liang-Yin Ke et al.
BIOMEDICINES (2020)
Two-Sample Mendelian Randomization Study of Lipid levels and Ischemic Heart Disease
Su Hyun Lee et al.
KOREAN CIRCULATION JOURNAL (2020)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics
E. Bjornson et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia
Martin Adiels et al.
DIABETES OBESITY & METABOLISM (2019)
Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis
Sarah A. Aroner et al.
DIABETOLOGIA (2019)
N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
Veronica J. Alexander et al.
EUROPEAN HEART JOURNAL (2019)
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance[S]
Bastian Ramms et al.
JOURNAL OF LIPID RESEARCH (2019)
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
Zahid Ahmad et al.
CIRCULATION (2019)
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
J. L. Witztum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors
Natalie C. Kegulian et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Gissette Reyes-Soffer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Apolipoprotein CIII and diabetes. Is there a link?
Eliza Christopoulou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Severe hypertriglyceridemia is primarily polygenic
Jacqueline S. Dron et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Genetic Determinants of Lipids and Cardiovascular Disease Outcomes A Wide-Angled Mendelian Randomization Investigation
Elias Allara et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis
Julio A. Lamprea-Montealegre et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms
Changting Xiao et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137895 Individuals
Anders B. Wulff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals
Rain Yamamoto et al.
ATHEROSCLEROSIS (2018)
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease
Oliviero Olivieri et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
Bastian Ramms et al.
CURRENT OPINION IN LIPIDOLOGY (2018)
High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis)
Sarah A. Aroner et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
Majken K. Jensen et al.
CIRCULATION (2018)
Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk
Allyson M. Morton et al.
JCI INSIGHT (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Natural History (up to 15 years) of Platelet Count in 84 Patients with Familial Hyperchylomicronemia Due to Lipoprotein Lipase Deficiency
Daniel Gaudet et al.
Journal of Clinical Lipidology (2017)
Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine
Javeed Jattan et al.
JOURNAL OF LIPID RESEARCH (2017)
The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation
Meenakshi Sundaram et al.
JOURNAL OF LIPID RESEARCH (2017)
Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity
Danish Saleheen et al.
NATURE (2017)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
Sumeet A. Khetarpal et al.
NATURE MEDICINE (2017)
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
Mengdie Luo et al.
SCIENTIFIC REPORTS (2017)
Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism
Anna Wolska et al.
ATHEROSCLEROSIS (2017)
Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk The EPIC-Norfolk Prospective Population Study
Julian C. van Capelleveen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja-Riitta Taskinen et al.
CURRENT ATHEROSCLEROSIS REPORTS (2016)
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
Andres Digenio et al.
DIABETES CARE (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia
Allyson M. Morton et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
Juraj Koska et al.
JOURNAL OF LIPID RESEARCH (2016)
Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results
Xiaohong Yang et al.
JOURNAL OF LIPID RESEARCH (2016)
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Geesje M. Dallinga-Thie et al.
CURRENT CARDIOLOGY REPORTS (2016)
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Peter P. Toth
VASCULAR HEALTH AND RISK MANAGEMENT (2016)
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity Multicenter Tracer Kinetic Study
Jan Boren et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
Frank M. Sacks
CURRENT OPINION IN LIPIDOLOGY (2015)
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
Moritz C. Wyler von Ballmoos et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
Karin Avall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
Giuseppe Danilo Norata et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease
Alison B. Kohan
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2015)
Mendelian randomization of blood lipids for coronary heart disease
Michael V. Holmes et al.
EUROPEAN HEART JOURNAL (2015)
The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
Hussein N. Yassine et al.
PLOS ONE (2015)
Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src
Yue Shi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Rare Variant APOC3 R19X Is Associated With Cardio-Protective Profiles in a Diverse Population-Based Survey as Part of the Epidemiologic Architecture for Genes Linked to Environment Study
Dana C. Crawford et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families
A. E. Bochem et al.
CLINICAL GENETICS (2014)
Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease
Beatriz Talayero et al.
JOURNAL OF LIPID RESEARCH (2014)
Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph
Fei Wang et al.
PHYSIOLOGICAL REPORTS (2014)
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease Role of High-Density Lipoprotein-Proteome Remodeling
Meliana Riwanto et al.
CIRCULATION (2013)
Common variants associated with plasma triglycerides and risk for coronary artery disease
Ron Do et al.
NATURE GENETICS (2013)
Docosahexaenoic acid suppresses the expression of FoxO and its target genes
Yu-Jen Chen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease
Majken K. Jensen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
Sandrine Caron et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Heterozygosity for a Loss-of-Function Mutation in GALNT2 Improves Plasma Triglyceride Clearance in Man
Adriaan G. Holleboom et al.
CELL METABOLISM (2011)
Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease
Carlos O. Mendivil et al.
CIRCULATION (2011)
Postprandial lipoprotein metabolism: VLDL vs chylomicrons
Katsuyuki Nakajima et al.
CLINICA CHIMICA ACTA (2011)
Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
Carlos O. Mendivil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
Chunyu Zheng et al.
CIRCULATION (2010)
Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients
M. Clemente-Postigo et al.
CLINICAL BIOCHEMISTRY (2010)
ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
Anne Hiukka et al.
DIABETES (2009)
Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans
Mirjana Pavlic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: The Hoorn Study
Peter G. Scheffer et al.
CLINICAL CHEMISTRY (2008)
Plasma apolipoprotein C-III transport in centrally obese men: Associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism
Dick C. Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions
Chunyu Zheng et al.
JOURNAL OF LIPID RESEARCH (2007)
APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome
Michael Miller et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
Akio Kawakami et al.
CIRCULATION (2006)
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics
DC Chan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells
A Kawakami et al.
CIRCULATION (2006)
Apolipoprotein B:: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis
SO Olofsson et al.
JOURNAL OF INTERNAL MEDICINE (2005)
A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes
P Davidsson et al.
JOURNAL OF LIPID RESEARCH (2005)
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes
A Hiukka et al.
DIABETOLOGIA (2005)
Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes
L Juntti-Berggren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
J Altomonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients
SJ Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
BA Laffitte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
K Olin-Lewis et al.
JOURNAL OF LIPID RESEARCH (2002)
Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration
DC Chan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skålén et al.
NATURE (2002)
Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians
S Chhabra et al.
BMC GENETICS (2002)
Differential metabolism of human VLDL according to content of ApoE and ApoC-III
K Tomiyasu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Mobilisation of triacylglycerol stores
GF Gibbons et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Share Paper
